Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Cysteine in Erythropoietic Protoporphyria
NCT00004940Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- May 1996
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of Acetium in erythropoietic protoporphyria (EPP), sponsored by Brigham and Women's Hospital. Started May 1996; status: completed.
02
Drugs
Acetium
03
Conditions
erythropoietic protoporphyria (EPP)
Beyond the preview
Go deeper on NCT00004940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004940.